Brain+ ApS Cash Flow Conversion Efficiency

Latest as of June 2025: -0.964x

Brain+ ApS cash flow conversion efficiency. Based on the latest financial reports, Brain+ ApS (BRAINP) has a cash flow conversion efficiency ratio of -0.964x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-13.93 Million ≈ $-2.18 Million USD) by net assets (Dkr14.45 Million ≈ $2.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Brain+ ApS (2017–2024)

Cash flow conversion efficiency of Brain+ ApS from 2017 to 2024. This chart illustrates how Brain+ ApS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Brain+ ApS stock price for real-time trading data and today's change.

Brain+ ApS Cash Flow Conversion Ratio Explained

Brain+ ApS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Brain+ ApS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brain+ ApS ranked by their cash flow conversion efficiency. Also see BRAINP market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
REVITALIST L.A.W. LTD F:4DO	N/A
National World PLC LSE:NWOR	0.024x
Norrland Gold Corp V:NORR	-0.074x
Lunai Bioworks Inc. NASDAQ:LNAI	0.107x
Vivanco Gruppe AG F:VG0K	0.164x
International Parkside Products Inc V:IPD	0.368x
Invinity Energy Systems PLC LSE:IES	-0.083x
ALGERNON PHARMACEUT. A F:AGW0	N/A

Annual Cash Flow Conversion Efficiency for Brain+ ApS (2017–2024)

The table below shows the annual cash flow conversion efficiency of Brain+ ApS from 2017 to 2024. Review Brain+ ApS free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Dkr10.98 Million ≈ $1.72 Million	Dkr-9.25 Million ≈ $-1.45 Million	-0.842x	+23.90%
2023-12-31	Dkr12.38 Million ≈ $1.94 Million	Dkr-13.71 Million ≈ $-2.14 Million	-1.107x	-350.45%
2022-12-31	Dkr16.38 Million ≈ $2.56 Million	Dkr-4.03 Million ≈ $-629.80K	-0.246x	+39.61%
2021-12-31	Dkr20.60 Million ≈ $3.22 Million	Dkr-8.38 Million ≈ $-1.31 Million	-0.407x	-110.70%
2020-12-31	Dkr1.92 Million ≈ $300.09K	Dkr7.29 Million ≈ $1.14 Million	3.801x	+74401.98%
2019-12-31	Dkr3.20 Million ≈ $500.19K	Dkr16.31K ≈ $2.55K	0.005x	-99.56%
2018-12-31	Dkr6.24 Million ≈ $975.54K	Dkr7.29 Million ≈ $1.14 Million	1.169x	+7.41%
2017-12-31	Dkr6.70 Million ≈ $1.05 Million	Dkr7.29 Million ≈ $1.14 Million	1.089x	--

About Brain+ ApS

CO:BRAINP Denmark Health Information Services

Market Cap

$744.48K

Dkr4.76 Million DKK

Market Cap Rank

#30844 Global

#146 in Denmark

Share Price

Dkr0.00

Change (1 day)

+0.00%

52-Week Range

Dkr0.00 - Dkr0.02

All Time High

Dkr4.87